Intersect ENT

YTD

ALL

Why Robinhood?

You can watch Intersect ENT and buy or sell other stocks, ETFs, and their options commission-free!

About XENT

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA.

CEO

Thomas A. West, MBA

CEOThomas A. West, MBA

Employees

—

Employees—

Headquarters

Menlo Park, California

HeadquartersMenlo Park, California

Founded

2003

Founded2003

Employees

—

Employees—

XENT Key Statistics

Market cap

954.90M

Market cap954.90M

Price-Earnings ratio

-5.63

Price-Earnings ratio-5.63

Dividend yield

—

Dividend yield—

Average volume

733.84K

Average volume733.84K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$28.25

52 Week high$28.25

52 Week low

$15.92

52 Week low$15.92

People also own

Based on the portfolios of people who own XENT. This list is generated using Robinhood data, and it’s not a recommendation.